| Pharmaceutical active ingredients: |
| HexetidineTriclosan |
| Available forms, composition and doses of Oraldene: |
| Solution; Local Oral; Hexetidine 0.1%; Triclosan 0.3 % |
| Oraldene medical category: |
| Human:Mouth / throat preparationsMouthwashes and gargles |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A01AB12 - HexetidineD08AE04 - TriclosanD09AA06 - Triclosan |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Triocil | Hexetidine | Unidentified Pharmaceutical Company |
| Triscol | Hexetidine | Unidentified Pharmaceutical Company |
| Vagi-Hex | Hexetidine | Drossapharm; Commerz Trading International |
| Anso | Hexetidine; Lidocaine Hydrochloride; Pentosan Polysulfate Sodium; Triamcinolone Acetonide | Lacer; CNW Hong Kong; Medreich Kali Macau |
| Nifluril Dental Gel | Hexetidine; Niflumic Acid Glycinamide | Bristol-Myers Squibb; UPSA Laboratoires |
| Barbidorm | Hexobarbital | Unidentified Pharmaceutical Company |
| Citopan | Hexobarbital | Unidentified Pharmaceutical Company |
| Cyclonal | Hexobarbital | Unidentified Pharmaceutical Company |
| Cyclopan | Hexobarbital | Unidentified Pharmaceutical Company |
| Enhexymal | Hexobarbital | Unidentified Pharmaceutical Company |